HLTF and uterine cancer: Several studies have demonstrated that the HLTF promoter is hypermethylated in human colorectal [11-19], gastric [13,20,21], esophageal [13,22] and uterine cancers [23], suggesting that HLTF silencing may play a crucial role in cancer.